Steven Cohen Trevi Therapeutics, Inc. Put Options Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TRVI
# of Institutions
110Shares Held
70.1MCall Options Held
201KPut Options Held
137K-
Nea Management Company, LLC Timonium, MD11.4MShares$46.3 Million3.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$30 Million1.33% of portfolio
-
Viking Global Investors LP4.4MShares$17.9 Million0.06% of portfolio
-
Rubric Capital Management LP New York, NY4.21MShares$17.1 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$14.3 Million0.0% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $237M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...